Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference

Valeant Pharmaceuticals International,Inc.
Posted on: 27 Sep 17
Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference

PR Newswire

LAVAL, Quebec, Sept. 27, 2017

LAVAL, Quebec, Sept. 27, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Paul S. Herendeen, executive vice president, Finance, and chief financial officer; Linda LaGorga, senior vice president, Finance, and treasurer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications; are scheduled to participate at the Deutsche Bank 25th Annual Leveraged Finance Conference in Scottsdale, Ariz. on Oct. 4, 2017 at 8:00 a.m. MST (11:00 a.m. EDT).

A live webcast and audio archive of the event will be available on the Investor Relations page of the Valeant web site at:

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Investor Contact:                              

Media Contact:

Arthur Shannon                                  

Lainie Keller   

(514) 856-3855                                    

(908) 927-0617

(877) 281-6642 (toll free)                    



View original content:

SOURCE Valeant Pharmaceuticals International, Inc.

PR Newswire

Last updated on: 27/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.